Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2005 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00089687
First received: August 10, 2004
Last updated: October 23, 2007
Last verified: January 2005

August 10, 2004
October 23, 2007
April 2004
Not Provided
pharmacokinetic assessment
Same as current
Complete list of historical versions of study NCT00089687 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
GBR 12909 Study in Cocaine Experienced African American Volunteers

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.

Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.

Interventional
Phase 1
Primary Purpose: Treatment
Cocaine-Related Disorders
Drug: GBR 12909
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
10
May 2005
Not Provided

Inclusion Criteria:

  • Must be within 20% of ideal body weight and must weigh at least 45 kg.
  • Must understand the study procedures and provide written informed consent.
  • Must meet DSM-4 criteria for abuse or dependence on cocaine.
  • Must be non-treatment seeking at the time of the study.

Exclusion Criteria:

  • Please contact the study site for more information.
Both
18 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00089687
NIDA-CPU-0005-1
Not Provided
Not Provided
National Institute on Drug Abuse (NIDA)
Not Provided
Principal Investigator: Louis Cantilena, M.D. Uniformed Services University of Health Science
National Institute on Drug Abuse (NIDA)
January 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP